AstraZeneca PLC operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares AstraZeneca PLC with three other
pharmaceutical manufacturers in Europe:
Lonza Group AG
of SWITZERLAND
(2019
sales of 5.92 billion Swiss Francs [US$6.52 billion]
of which 70%
was Pharma&Biotech),
Merck KGaA
of GERMANY
(16.15 billion Euros [US$19.25 billion]
of which 42%
was Life Science), and
Novo Nordisk As
which is
based in DENMARK
(122.02 billion Danish Kroner [US$19.53 billion]
of which 84%
was Diabetes and obesity).
Sales Analysis.
During the year ended December of 2019, sales at
AstraZeneca PLC were £19.06 billion (US$25.52 billion).
This
is
an
increase of 14.8%
versus 2018, when the company's sales were £16.60 billion.